Clinical Trial

Spirulina Derivative for Radiation Esophagitis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 8, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy and safety of a Spirulina-derived product in preventing and treating radiation-induced esophagitis in esophageal cancer patients undergoing intensity-modulated radiotherapy (IMRT).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-21.
Trial Details
NCT Number NCT07324018
Lead Sponsor West China Hospital
Conditions Radiation-induced Esophagitis
Enrollment 70 participants
Start Date 2026-01-12
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-08